comparing glp-1 agonists GLP-type therapies for weight loss in those without diabetes. Two glucagon-like peptide-1 receptor (GLP-1 RAs) (#semaglutide and #liraglutide) and one dual agonist (#tirzepatide) have been FDA-approved for #weightloss in adults Mapping the effectiveness and risks

Chemical modifications of GLP-1RAs have increased the medicinal value of these agonists for the treatment of diabetes

Gretchen E

For comprehensive overview of all options, check our comparison of weight loss medications in 2026

Thanks to new technology that streamlines the prior authorization and appeal process, the process can take minutes, but the response rate from insurance companies to review the appeal and decide can vary from hours to days, she says

doi: 10.1093/eurheartj/ehz486 6 American Diabetes A

Diabetol Metab Syndr 17(1):315 McCrimmon RJ, Catarig AM, Frias JP, Lausvig NL, le Roux CW, Thielke D et al (2020) Effects of once-weekly semaglutide vs once-daily Canagliflozin on body composition in type 2 diabetes: a substudy of the SUSTAIN 8 randomised controlled clinical trial